NJCRI=Research
Why NJCRI
is a Leader in Research and Partnerships
The North
Jersey Community Research Initiative (NJCRI)
continues to distinguish itself as a leading force in public health research, education,
and partnerships, both domestically and globally. Through a steadfast
commitment to innovation, collaboration, and scientific rigor, NJCRI has
demonstrated excellence in addressing complex health challenges, particularly in the fields of HIV, hepatitis, STIs, harm reduction, and underserved populations.
In the 2023–2024 calendar years, NJCRI has actively contributed to the global scientific
conversation by presenting original research and field-based innovations at
prestigious conferences across the United States and internationally. This
level of visibility and engagement underscores NJCRI’s role as not only a
community-centered organization, but also a thought leader in the public health arena
May 2025 European Association for the Study of the Liver
The European Association for the Study of the Liver (EASL) Congress 2025, held from May 7–10 in Amsterdam, convened over 8,000 global experts in hepatology. The event showcased more than 2,500 abstracts and featured a comprehensive scientific program, including hands-on workshops and expert lectures, covering all facets of liver health.
For the North Jersey Community Research Initiative (NJCRI), insights from EASL 2025 are particularly valuable. Director of Research Corey DeStefano and Leading Program Manager Kevin Leyden represented the agency. The congress addressed pressing issues such as viral hepatitis, metabolic liver diseases, and liver cancer, aligning with NJCRI’s commitment to advancing liver health and research. The emphasis on public health strategies, including prevention and early detection, offers actionable knowledge to enhance NJCRI’s community programs and research initiatives.
Engaging with the latest developments from EASL 2025 empowers NJCRI to integrate cutting-edge findings into its mission, fostering improved liver health outcomes within the communities it serves.
- Global Hepatitis Summit Paris France 4/25-4/28/2023
- American Society for Nutrition Boston, MA 7/22-7/25/2023
- ID Week 10/11-10/14/2023 Boston, MA
- Internation Conference on Hepatitis in Substance Users INHSU Conference Geneva, Switzerland 10/16-10/20/2023
- American Public Health Conference (APHA) Conference Atlanta, GA 11/12-11/15/2023
- IVHEM Amsterdam, Netherlands 12/1-12/3/2023
- World Hepatitis Summit, Lisbon, Portugal 4/9-4/11/2023
- National Latinx Conference on HIV, Hepatitis and STIs San Jose, TX May 2-4, 2024.
- Synchronicity Conference National Conference on HIV/HCV/STI/Harm Reduction, LGBTQ Health, 5/31/2024-6/3/2024 Washington, DC
- ADLM Conference July 28 – August 4, 2024, Chicago, Illinois
- National Ryan White Conference on HIV Care and Treatment, Washington, DC August 20-23, 2024.
- Philadelphia Transgender Wellness Conference Philadelphia, PA 9/7-9/9/2024
- International Conference on Health and Hepatitis in Substance Users, Athens Greece, October 8-11, 2024.
- ID Week, Los Angeles, CA October 16-19, 2024.
- American Public Health Association (APHA) October 27-30, 2024 Minneapolis, MN
